Intra-Cellular Therapies Company
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Founded Date:
2002
Employee Number:
51-100
Funding Status:
IPO
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
New York, New York, United States
Estimated Revenue:
$1M to $10M